Pevion Biotech successfully applies its proprietary virosome-based technology platforms to the development of efficient and safe prophylactic/therapeutic vaccines. Additionally, Pevion Biotech gives access to these platforms (PeviPROTM and PeviTERTM) as well as to the virosome-based drug delivery platform (PeviPHARTM) to third parties. Pevion Biotech is located in Bern, Switzerland and has 21 employees. Pevion Biotech´s high qualified scientists and development personnel are specialized in bringing concepts for novel vaccines and drug delivery systems from research into clinical development.
Pevion Biotech´s virosomes are already market approved and can be manufactured on a large scale under GMP.
Pevion Biotech´s technology can be adapted to meet the various requirements of a state-of-the-art-carrier system. Pevion Biotech is a partner in vaccine formulation and drug delivery to pharmaceutical companies and research institutions.
| Contact Details: |
| Rehhagstrasse 79 |
| Bern |
| |
| CH-3018 |
| Switzerland |
| Tel: | 41 +31 980 62 03 |
| Fax: | 41 +31 980 62 18 |
| Email: | info@pevion.com |
| WWW: | www.pevion.com/
|
| |
Recent Publications by Pevion Biotech Ltd.: |  |
A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses.
The purpose of a vaccine is the induction of effective cellular and/or... | 7th December, 2007
| Pevion Biotech Ltd., Rehhagstrasse 79, CH-3018 Bern, Switzerland.
| Vaccine. 2007 Oct 10;25(41):7065-74. Epub 2007 Aug 14.
DOI Direct Link |
Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.
Influenza virosomes are an efficient antigen carrier and adjuvant system... | 6th December, 2007
| Pevion Biotech, Rehhagstrasse 79, 3018 Bern, Switzerland.
| Expert Rev Vaccines. 2007 Oct;6(5):711-21.
DOI Direct Link |
Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes.
Malaria remains a serious cause of morbidity and mortality in millions of... | 11th August, 2007
| Pevion Biotech Ltd., Bern, Switzerland.
| Wien Klin Wochenschr. 2006;118(19-20 Suppl 3):50-7.
DOI Direct Link |
Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
Virus-specific CD8(+) T cells are thought to play an important role in... | 10th June, 2006
| Pevion Biotech Ltd, Rehhagstrasse 79, CH-3018 Bern, Switzerland.
| Int Immunol. 2005 Jun;17(6):695-704. Epub 2005 Apr 20.
DOI Direct Link |
Peptides delivered by immunostimulating reconstituted influenza virosomes.
Vaccines have been well accepted and used effectively for more than 100... | 5th January, 2006
| Pevion Biotech Ltd., Bern, Switzerland.
| J Pept Sci. 2005 Nov;11(11):707-12.
DOI Direct Link |
→View more Pevion Biotech Ltd. research publications. |
Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 693 times since April 2007, the link to the organisation's website has been followed 103 times
Recent Search Terms used to find this page: Virosomal Vaccine Platforms pevion biotech | pevion biotech | pevion | pevion link | biotechnology company in bern | pevion | swine flu vaccine carrier system for delievery | pevion | find details on carrier in biotech | pevion | .
Search for more companies in Bern
Search for more companies in
This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for
Pevion Biotech Ltd.
